R&Dplatform

Contact Us

 

 

  

Address: Beijing's xizhimen south street, xicheng district

 

The British garden 1 floor. Room 824

 

Zip code: 100035

 

Telephone: 010-58562339

 

Fax: 010-58562339

 

Email address: cngjzj@163.com

 

Web site (click on the url link directly left) :

 

http://www.cngjzj.com/

 

Blog (click on the url link directly left) :

http://blog.sina.com.Cn/CNGJZJ

 

To xizhimen south street, xicheng district building to the British garden route

L airport line 1

Take the airport shuttle from the airport, the dongzhimen station transfer to metro line 2 to xizhimen direction and get off at xizhimen station, from C outbound, go straight to the east 100 meters on the right side to xizhimen south street, north to walk to the t-junction namely to the British garden 1 floor downstairs.

L airport line 2

From the capital airport take airport bus to xidan, get off at no.22, take a taxi to xizhimen south street English garden 1 floor.

L bus subway near:

106 bus GuanYuan: 107 road, express way

Bus: xizhimen south road 387, 44 road, inner ring 800, 816 road, inner ring 820, 845 road

Che zhuang: subway line two

Xizhimen subway: metro line 2

Buses and attempts: 107 road, 118 road, 701 road

Buses and north zhuang: 209 road, 375 road, 392 road

 

Your position is: Home >> R&Dplatform >> R&Dplatform

Chengdu University of Traditional Chinese Medicine "Hand in Hand" Bixiopu Cancer

2018年12月31日

复制链接 打印 大 中 小

<



Chengdu University of Traditional Chinese Medicine "Hand in Hand" Bixiopu Cancer Research Institute: Joint Research and Development of New Cancer Drugs
Drama Squad 2018-10-20 01:10


This picture is taken from the People's Daily client. On the afternoon of October 9th, the signing ceremony of the strategic cooperation agreement between the Cancer Institute of Chengdu University of Chinese Medicine and the Bixiao Cancer Institute and the Logo of the Bixiopu Cancer Institute was held at the Wenjiang Campus of the school.
The event was attended by a large crowd, 1989 Nobel Prize winner in Physiology or Medicine, Academician of the American Academy of Sciences, Academician of the American Academy of Arts and Sciences, Professor Jiannuofu Bishop, Academician of the Royal Academy of Sciences, and Apple trademark designer. Mr. Rob Janoff, Professor Robert Lloyd, Academician of the Royal Academy of Sciences, and Professor Naishimisi, Academician of the Royal Academy of Sciences, Feiershe, director of Stanford University's Institute of Oncology, Weiermu, director of the University of Utah Cell Response and Regulation Program, and Steven, director of the Department of Developmental Genetics of Nanjing Medical University. , witnessed the strong association of Chinese and Western medicine and opened a new chapter in cancer prevention and treatment research.
President Yushuguang delivered a welcome speech. Cancer, he said, would be the leading cause of death in the twenty-first century, the most important obstacle to increasing life expectancy in countries around the world and one of the greatest health challenges facing humanity today. In the 100-year history of cancer research, surgical therapy, chemotherapy, radiation therapy, targeted therapy, and immunotherapy have emerged. American and Japanese scientists who discovered negative immunomodulatory cancer therapy have also won the 2018 Nobel Prize in Physiology or Medicine. Chinese medicine treatment is also one of the special treatments for cancer, which has the effect of reducing poison and increasing sensitivity in combination with chemotherapy and chemotherapy. It can effectively improve the clinical symptoms of patients and improve the quality of life; It can effectively improve the tumor stability rate and prolong the survival time. It can effectively improve the immune status and other characteristics and advantages of patients. Yushuguang pointed out that the cooperation between the Cancer Research Institute of Chengdu University of Traditional Chinese Medicine and the Bixiao Cancer Research Institute is a major event and joy for the Chengdu University of Traditional Chinese Medicine to achieve scientific development and leapfrog the development process. It is an important measure to speed up the "double first-class" construction and achieve academic revitalization of Chinese medicine. It will promote the accelerated progress of school connotation construction.
At the meeting, Professor Tianli, vice president of the Clinical Medical School / Affiliated Hospital, and Dr. Bixiao, director of the Yangdun Cancer Research Institute, signed a cooperation agreement on behalf of the two sides of the school and enterprises. The principal, Yushuguang, awarded the joint laboratory to the two sides. The cooperation between the Oncology Research Institute of Chengdu University of Traditional Chinese Medicine and the Bixiao Cancer Research Institute will be based on the western region of China and integrate the drug plant resources, traditional Chinese medicine, and the cancer foundation and transformation research in the Southwest region organically, through complementary advantages, cooperation and innovation. Design, discover, and develop breakthrough and innovative drugs and therapies that are more effective and have fewer side effects than traditional cancer therapies, benefiting more patients. According to feng Ming, director of the oncology research institute of Chengdu University of traditional Chinese medicine, the macro-guidance of Chinese medicine in the prevention and treatment of diseases has its own theoretical advantages, and Western medicine has modern scientific and technological advantages in drug extraction and drug analysis, and the two advantages complement each other. Like Tuyouyouqinghaosu's discovery and extraction, when Chinese medicine takes the fast train of modern scientific development, it will surely bring more "gifts" to the world.
The conference also held the launch ceremony of the Logo of the Bixiao Cancer Research Institute. The designer Jiannuofu explained the design concept. Jiannuofu, Li Xiaobu, Lloyd, Smith and other attendees signed congratulations on the Logo panel.
Dr Bixiao, Director of the Cancer Research Institute of Yangdun, gave a presentation on the direction of research and development of anti-cancer drugs.
After the meeting, Jiannuofu and other guests walked around the campus, visited the school museum, had close contact with the Chinese medicine culture, and personally experienced the wonderful massage of Chinese medicine.
It is understood that the Bixiao Cancer Institute is the only basic research institution in the world named after Professor Bishop for cancer treatment. Professor Bishop and Wamusi in the 1980s(Harold E. Professor Varmus) collaborated to discover the first human prooncogene C-Src. Their findings explain how cancer is formed from changes in normal genes in cells, bringing cancer research to the genetic level, and their proposed "oncogene" has become a milestone in the process of cancer biology exploration. At present, the Bixiao Cancer Research Institute has in-depth research in the fields of cell biology, small molecule RNA biology, cancer gene biology, cancer stem cells, and precision anti-cancer medicine. (Originally entitled: "School enterprises jointly develop new anti-cancer new drugs and new therapies. Chinese medicine will bring more gifts to the world.")